$200K - $250K*
The Director, KOL Engagement Marketing, will be responsible for the development and implementation of promotional medical education strategies and tactics for the US launch of lifileucel, a cell therapy for metastatic melanoma, in partnership with US Sales, Commercial Operations, Medical, Regulatory Affairs, Legal and other cross-functional partners.
The ideal candidate is someone with experience supporting the launch of one of the 10 FDA-approved products for metastatic melanoma with an entrepreneurial spirit looking for an opportunity to launch an innovative cell therapy in metastatic melanoma. The Director, KOL Engagement Marketing will report to the Senior Director, Marketing -- Melanoma.
Valid through: 2020-4-2